LC3 dot-like immunostaining is correlated with shorter survival in KRAS mutated CRC, whereas high cytoplasmic p62 is negatively associated with poor survival in KRAS mutated CRC [20]. The gene discussed is KRAS; the disease is colorectal carcinoma.